Five-Year Multicenter Cohort Study of Vaginal Microbiome and STIs Progression
A Five-Year Longitudinal Follow-Up Study on Vaginal Microbiome Characteristics and Their Association With Reproductive Tract STIs and Cervical Lesion Progression Based on a Multicenter Cohort
- To elucidate the long-term impact of vaginal microbiome and the dynamic trends of its characteristics across 5 years follow-up visits on the clinical outcomes of sexually transmitted infections (STIs).
- To determine the long-term effects of specific microbial infections (Up6, MH) and vaginal microbiome characteristics on the progression of STIs.
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
This multicenter, observational study is a 5-year longitudinal follow-up extending the CALM2004 cohort. It aims to enroll 7,574 women aged 18-60 to investigate the long-term impact of vaginal microbiome characteristics and sexually transmitted infections (STIs) on cervical lesion progression. By collecting vaginal secretions, and blood samples, the study will evaluate the 5-year cumulative incidence of CIN2+ and determine how specific microbial infections (e.g., Up6, MH) influence clinical outcomes, providing high-level evidence for cervical cancer prevention strategies.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Muxuan Chen, Doctor
- Phone Number: +8613580561916
- Email: muxuanchen@126.com
Study Locations
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China
- Peking University First Hospital
-
Contact:
- Bingbing Xiao, Doctor
-
-
Fujian
-
Fuzhou, Fujian, China
- Fujian Maternity and Child Health Hospital
-
-
Gansu
-
Lanzhou, Gansu, China
- The First Hospital of Lanzhou University
-
Contact:
- Haitao Yu, Doctor
-
Lanzhou, Gansu, China
- Gansu Provincial Hospital
-
Contact:
- Lianhua Wei, Doctor
-
-
Guangdong
-
Chaozhou, Guangdong, China
- Chaozhou Central Hospital
-
Contact:
- Fen lin, Doctor
-
Foshan, Guangdong, China
- Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
-
Contact:
- Chaoxin Jiang, Doctor
-
Guangzhou, Guangdong, China
- The First Affiliated Hospital, Sun Yat-sen University
-
Contact:
- Bin Huang, Doctor
-
Guangzhou, Guangdong, China
- Nanfang Hospital, Southern Medical University
-
Contact:
- Dehua Sun, Doctor
-
Guangzhou, Guangdong, China
- The Fifth Affiliated Hospital of Southern Medical University
-
Contact:
- Xiaoyan Li, Doctor
-
Guangzhou, Guangdong, China
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Contact:
- Yingchun Zhou, Doctor
-
Guangzhou, Guangdong, China
- The Fifth Affiliated Hospital of Guangzhou Medical University
-
Contact:
- Liang Peng, Doctor
-
Guangzhou, Guangdong, China
- The Third Affiliated Hospital of Southern Medical University
-
Contact:
- Xuefeng Wang, Doctor
-
Guangzhou, Guangdong, China
- The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Contact:
- Kewei Zhao, Doctor
-
Guangzhou, Guangdong, China
- Zhujiang Hospital of Southern Medical University
-
Guangzhou, Guangdong, China
- Guangzhou Baiyun District Taihe People's Hospital
-
Huizhou, Guangdong, China
- Huizhou Municipal Central Hospital
-
Contact:
- Xianjin Wu, Doctor
-
Shaoguan, Guangdong, China
- Yuebei People's Hospital
-
Contact:
- Pingsen Zhao, Doctor
-
Shenzhen, Guangdong, China, 518028
- Shenzhen Maternity & Child Healthcare Hospital
-
Contact:
- Yuting Dai
- Phone Number: 0755-82869849
-
Shenzhen, Guangdong, China
- Luohu District People's Hospital
-
Shenzhen, Guangdong, China
- Southern Medical University Shenzhen Hospital
-
Contact:
- Hongwei Zhou, Doctor
-
Shenzhen, Guangdong, China
- The Seventh Affiliated Hospital, Sun Yat-sen University
-
Contact:
- Zhaofan Luo, Doctor
-
Zhongshan, Guangdong, China
- Zhongshan Xiaolan People's Hospital
-
Contact:
- Wandang Wang, Doctor
-
Zhuhai, Guangdong, China
- Zhuhai Maternal and Child Health Hospital
-
-
Guangxi
-
Nanning, Guangxi, China
- The First Affiliated Hospital of Guangxi Medical University
-
Contact:
- Faquan Lin, Doctor
-
-
Guizhou
-
Guiyang, Guizhou, China
- Affiliated Hospital of Guizhou Medical University
-
Contact:
- Fan Lu, Doctor
-
Zunyi, Guizhou, China
- Zunyi First People's Hospital
-
Contact:
- Kaifeng Wu, Doctor
-
-
Hainan
-
Haikou, Hainan, China
- Hainan General Hospital
-
Contact:
- Bo Wang, Doctor
-
-
Heilongjiang
-
Mudanjiang, Heilongjiang, China
- Hongqi Hospital Affiliated to Mudanjiang Medical University
-
Contact:
- Chunxia Guo, Doctor
-
Qiqihar, Heilongjiang, China
- Qiqihar First Hospital
-
-
Henan
-
Zhengzhou, Henan, China
- Henan Provincial People's Hospital
-
Contact:
- Jing Zhao, Doctor
-
-
Inner Mongolia
-
Hohhot, Inner Mongolia, China
- Inner Mongolia Autonomous Region Maternal and Child Health Hospital
-
Contact:
- Jing Sha, Doctor
-
-
Jiangsu
-
Lianyungang, Jiangsu, China
- The Second People's Hospital of Lianyungang
-
Contact:
- Wei Liang, Doctor
-
-
Jilin
-
Jilin City, Jilin, China
- Jilin City Central Hospital
-
Contact:
- Guijie Zhang, Doctor
-
-
Liaoning
-
Shenyang, Liaoning, China
- The First Hospital of China Medical University
-
Contact:
- Ruizhe Wang, Doctor
-
-
Ningxia
-
Yinchuan, Ningxia, China
- General Hospital of Ningxia Medical University
-
Contact:
- Feng Li, Doctor
-
-
Qinghai
-
Xining, Qinghai, China
- Qinghai Red Cross Hospital
-
Contact:
- Dengyun Ma, Doctor
-
-
Shandong
-
Jinan, Shandong, China
- Jinan Central Hospital
-
Contact:
- Shuyi Han, Doctor
-
Jinan, Shandong, China
- Shandong Provincial Hospital
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China
- Shanghai East Hospital, Tongji University
-
Contact:
- Jingxin Cheng, Doctor
-
-
Shanxi
-
Changzhi, Shanxi, China
- Changzhi People's Hospital
-
Contact:
- Guoxiang Zhang, Doctor
-
-
Sichuan
-
Dazhou, Sichuan, China
- Dazhou Integrated Traditional Chinese and Western Medicine Hospital
-
Contact:
- Xuesu He, Doctor
-
Luzhou, Sichuan, China
- Affiliated Hospital of Southwest Medical University
-
Contact:
- Jinbo Liu, Doctor
-
-
Tibet
-
Lhasa, Tibet, China
- Tibet Autonomous Region People's Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
A total of 7,574 women aged 18-60 years who previously participated in the baseline of the CALM2004 multicenter cohort study will be recruited for this 5-year longitudinal follow-up. This is a multicenter study, and participants will be recruited through targeted invitations from the research team members. The study population consists of women with a broad spectrum of baseline vaginal microecological statuses and varying risks of STIs and cervical lesions.
Description
Inclusion Criteria:
- Female aged 18 to 60 years.
- Participants who previously participated in the baseline of the CALM2004 study.
- Volunteers who are recruited through targeted invitations and consent to participate in this study.
Exclusion Criteria:
- Pregnant women.
- Received treatment for reproductive tract infections or sexually transmitted infections (STIs) within the past month.
- Used broad-spectrum antibiotics, local genital probiotics, or vaginal suppositories within the past month.
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
CALM2004 Follow-up Cohort
A total of 7,574 women aged 18-60 who previously participated in the CALM2004 baseline study will be enrolled for a 5-year longitudinal follow-up. Participants will undergo comprehensive assessments including questionnaires, vaginal secretion collection for metagenomic sequencing, cervical exfoliated cells for TCT and STI nucleic acid testing, and venous blood testing. No specific interventions will be administered. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cumulative incidence of CIN2+ at 5 years
Time Frame: 5 years
|
The incidence rate of histologically confirmed Cervical Intraepithelial Neoplasia grade 2 or 3 (CIN2/3) or invasive cervical cancer occurring for the first time during the follow-up period, among participants who had no cervical lesions or were <CIN2 at baseline |
5 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
New incidence and progression rates of ASC-US+ cytological abnormalities
Time Frame: 5 years
|
ASC-US+ new incidence: First occurrence of ASC-US or higher cytological abnormality during follow-up in participants with normal baseline cytology. ASC-US+ progression: First occurrence of LSIL/HSIL or higher cytological abnormality during follow-up in participants with baseline ASC-US. Cytology is evaluated according to the Bethesda System for Reporting Cervical Cytology. |
5 years
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HPV and STI incidence, clearance, and persistent/recurrent infection rates
Time Frame: 5 years
|
HPV new infection: baseline negative, follow-up positive; HPV clearance: baseline positive, follow-up negative; HPV persistent infection: same genotype positive at both baseline and follow-up. STI new infection: baseline negative, follow-up positive; STI clearance: baseline positive, follow-up same genotype negative; STI recurrent infection: same genotype positive at both baseline and follow-up. |
5 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Chair: Hongwei Zhou, Doctor, Shenzhen Hospital of Southern Medical University
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CALM2004-5
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.